Skip to main content
# Title Department Research Year
11 Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors. Department of Pharmaceutical Organic Chemistry 2024
12 Regiodivergent biosynthesis of bridged bicyclononanes Department of Pharmacognosy 2024
13 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
14 Thunbergiside A: An unprecedented neolignan isolated from Gardenia thunbergia L. f. and the antifungal activity of selected phytochemicals Department of Pharmacognosy 2024
15 Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease Department of Pharmaceutical Analytical Chemistry 2024
16 Phenotypic detection of ESBL and MBL producing Klebsiella pneumoniae in critically ill patients with nosocomial pneumonia Department of Microbiology and Immunology 2024
17 Sertaconazole-PLGA nanoparticles for management of ocular keratitis Department of Pharmaceutics 2024
18 A surfactant-based quasi-hydrophobic deep eutectic solvent for dispersive liquid-liquid microextraction of gliflozins from environmental water samples using UHPLC/fluorescence detection Department of Pharmaceutical Analytical Chemistry 2024
19 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
20 Effects of lidocaine derived organic compounds on eosinophil activation and survival 2023